43 peer-reviewed studies on the supplements, nutrition, and lifestyle changes that you can start today to actively prevent your likelihood of developing invasive breast cancer. Click the pink button to the right to get started.
Articles and studies debating overdiagnosis and over treatment of DCIS is not new. What is new is a study that puts a real number on what overtreatment costs the U.S. in dollars.
Before the invention of the mammogram, there probably were breast cancers that could have been diagnosed at an earlier stage but were not. As we all know, finding cancers early results in better outcomes. By identifying breast cancers earlier, mammography improved the outcomes for many women.
In fact, a good friend of mine discovered her invasive breast cancer through a routine mammogram. Maribeth swears to me that mammorgrams save lives.
At the same time, mammograms find problems that either are not cancer or cause treatment that is not necessary, aka overdiagnosis and overtreatment.
“Owing to the widespread adoption of screening for breast cancer and improvements in the sensitivity of mammography, the diagnosis of ductal carcinoma in situ (DCIS) has increased dramatically over the past few decades. Historically, DCIS accounted for only 1% to 2% of all breast cancer diagnoses, but now it accounts for over 20%.“
According to a recent Medscape article, the number of DCIS diagnoses in 2014 was 35,591. Many cancer experts debate if DCIS should even be classified as cancer or perhaps cancer stage 0.
I am a cancer survivor and cancer coach. If you have been diagnosed with DCIS consider evidenced-based, non-toxic therapies to reduce your risk of progressing to breast cancer.
To learn more about DCIS and the evidence-based therapies that can help you prevent its spread into invasive breast cancer, please watch the video below:
To download the DCIS Guide, click here.
For more information on both conventional and non-conventional therapies for breast cancer, scroll down the page, post a question or a comment and I will reply ASAP.
“Sharpening a medical debate about the costs and benefits of cancer screening, a new report estimates that the U.S. spends $4 billion a year on unnecessary medical costs due to mammograms that generate false alarms, and on treatment of certain breast tumors unlikely to cause problems…
The cost estimates cover women ages 40-59…
Study authors Mei-Sing Ong and Kenneth Mandl say their findings indicate that the cost of breast cancer overtreatment appears to be much higher than previously estimated. Their $4 billion figure is the midpoint of a range that depends upon assumptions about the rates of false-positive mammograms and breast cancer overdiagnosis…
Apart from the financial cost of screening tests and treatment, false positives and overdiagnosis expose women to risks from additional medical procedures, not to mention psychological distress. It’s not uncommon for mammograms to turn up some apparent abnormality that has to be resolved with more imaging tests or a biopsy…